March 23, 2020 / 2:13 AM / 15 days ago

BRIEF-Suda Pharmaceuticals Enters Exclusive License Agreement With Mitsubishi Tanabe Pharma Korea Ltd

March 23 (Reuters) - Suda Pharmaceuticals Ltd:

* ENTERED EXCLUSIVE LICENSE AGREEMENT WITH MITSUBISHI TANABE PHARMA KOREA LTD

* AGREEMENT FOR SUPPLY OF ZOLPIMIST FOR SOUTH KOREA WITH TERM OF 10-YRS FROM FIRST COMMERCIAL SALE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below